Annapolis Junction, MD, April 07, 2016 -- Colfax Corporation (“Colfax”) (NYSE: CFX), a leading global manufacturer of gas- and fluid-handling and fabrication technology products and services, today announced that it will issue a press release providing financial results for the first quarter of 2016 at approximately 6:00 a.m. Eastern Standard Time (“EDT”) on Tuesday, May 3, 2016. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. EDT on that day, which will be open to the public through 877-303-7908 (U.S. callers) and 678-373-0875 (international callers) and referencing the conference ID number 75888280, or through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section.
Colfax’s financial results press release and supplemental financial information referenced on the call, if any, for the first quarter of 2016 will be available under the “Investors” section of Colfax’s website prior to the conference call. A link to a replay of the call will also be available on the Colfax website later that day.
ABOUT COLFAX CORPORATION — Colfax Corporation is a diversified global manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. Colfax is traded on the NYSE under the ticker "CFX." Additional information about Colfax is available at www.colfaxcorp.com.
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the U.S. Securities and Exchange Commission including its 2015 Annual Report on Form 10-K under the caption "Risk Factors." In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of this date hereof. Colfax disclaims any duty to update the information herein.
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.
Investor Contact: Terry Ross, VP of Investor Relations Colfax Corporation (301) 323-9054 [email protected]


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



